eMedicine Specialties > Dermatology > Reactive & Inflammatory Dermatoses

Asteatotic Eczema: Follow-up

Author: Christina K Anderson, MD, Consulting Staff, Department of Dermatology, Center Care Clinic
Coauthor(s): O Fred Miller III, MD, Emeritus Director, Department of Dermatology, Geisinger Medical Center; Susan Cooper, MB, ChB, MD, MRCGP, MRCP, Consultant Dermatologist and Honorary senior clinical lecturer Department of Dermatology, Churchill Hospital, Oxford, United Kingdom
Contributor Information and Disclosures

Updated: Sep 11, 2009

Follow-up

Deterrence/Prevention

See Medical Care.

Prognosis

Asteatotic dermatitis responds well to therapy; however, if the causative factors are not eliminated, recurrences are common.

Patient Education

For excellent patient education resources, visit eMedicine's Skin, Hair, and Nails Center. Also, see eMedicine's patient education article Eczema.

Miscellaneous

Special Concerns

Be aware that nonhealing areas of asteatotic dermatitis may represent allergic contact dermatitis or irritant contact dermatitis. The rare generalized form should provoke a search for underlying malignancy.

 
Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous Chief Editor, William D. James, MD, to the development and writing of this article.



More on Asteatotic Eczema

Overview: Asteatotic Eczema
Differential Diagnoses & Workup: Asteatotic Eczema
Treatment & Medication: Asteatotic Eczema
Follow-up: Asteatotic Eczema
Multimedia: Asteatotic Eczema
References

References

  1. Akimoto K, Yoshikawa N, Higaki Y, Kawashima M, Imokawa G. Quantitative analysis of stratum corneum lipids in xerosis and asteatotic eczema. J Dermatol. Jan 1993;20(1):1-6. [Medline].

  2. Cork MJ, Danby S. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nurs. Jul 23-Aug 12 2009;18(14):872, 874, 876-7. [Medline].

  3. Weismann K, Wadskov S, Mikkelsen HI, Knudsen L, Christensen KC, Storgaard L. Acquired zinc deficiency dermatosis in man. Arch Dermatol. Oct 1978;114(10):1509-11. [Medline].

  4. Warin AP. Eczéma craquelé as the presenting feature of myxoedema. Br J Dermatol. Sep 1973;89(3):289-91. [Medline].

  5. Greist MC, Epinette WW. Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol. Apr 1982;118(4):253-4. [Medline].

  6. Barker DJ, Cotterill JA. Generalized eczéma craquelé as a presenting feature of lymphoma. Br J Dermatol. Sep 1977;97(3):323-6. [Medline].

  7. Guillet MH, Schollhammer M, Sassolas B, Guillet G. Eczema craquelé as a pointer of internal malignancy--a case report. Clin Exp Dermatol. Nov 1996;21(6):431-3. [Medline].

  8. van Voorst Vader PC, Folkers E, van Rhenen DJ. Craquelé-like eruption in angioimmunoblastic lymphadenopathy. Arch Dermatol. Mar 1979;115(3):370. [Medline].

  9. Higgins EM. Eczema craquelé and internal malignancy. Clin Exp Dermatol. Jul 1997;22(4):206. [Medline].

  10. Lazar AP, Lazar P. Dry skin, water, and lubrication. Dermatol Clin. Jan 1991;9(1):45-51. [Medline].

  11. Cappiello L, Miller OF. Occlusive therapy of asteatotic dermatitis. Data presented at: Pennsylvania Academy of Dermatology: 1990.

  12. Day I, Lin AN. Use of pimecrolimus cream in disorders other than atopic dermatitis. J Cutan Med Surg. Jan-Feb 2008;12(1):17-26. [Medline].

  13. Wollina U. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol. 2007;8(3):157-73. [Medline].

  14. Schulz P, Bunselmeyer B, Brautigam M, Luger TA. Pimecrolimus cream 1% is effective in asteatotic eczema: results of a randomized, double-blind, vehicle-controlled study in 40 patients. J Eur Acad Dermatol Venereol. Jan 2007;21(1):90-4. [Medline].

  15. Gutman AB, Kligman AM, Sciacca J, James WD. Soak and smear: a standard technique revisited. Arch Dermatol. Dec 2005;141(12):1556-9. [Medline].

  16. Burton J, Holden C. Eczema, lichenification, and prurigo. In: Textbook of Dermatology. Vol 1. 6th ed. Oxford, England: Blackwell Science; 1998:644-45.

  17. Caplan RM. Superficial hemorrhagic fissures of the skin. Arch Dermatol. Apr 1970;101(4):442-51. [Medline].

  18. Fitzpatrick T, Johnson R, Wolff K. Asteatotic Dermatitis. In: Color Atlas and Synopsis of Clinical Dermatology. 3rd ed. New York, NY: McGraw-Hill; 1997:75.

  19. Murray H, Forsey RR. Eczema craquele. Arch Dermatol. 1975;111:1536.

Further Reading

Keywords

asteatotic eczema, asteatotic dermatitis, eczema craquelé, asteatosis, eczema craquelatum, xerotic eczema, winter itch, eczema hiemalis, eczema fendille, etat craquelé

Contributor Information and Disclosures

Author

Christina K Anderson, MD, Consulting Staff, Department of Dermatology, Center Care Clinic
Christina K Anderson, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Coauthor(s)

O Fred Miller III, MD, Emeritus Director, Department of Dermatology, Geisinger Medical Center
O Fred Miller III, MD is a member of the following medical societies: American Academy of Dermatology and Pennsylvania Medical Society
Disclosure: Nothing to disclose.

Susan Cooper, MB, ChB, MD, MRCGP, MRCP, Consultant Dermatologist and Honorary senior clinical lecturer Department of Dermatology, Churchill Hospital, Oxford, United Kingdom
Susan Cooper, MB, ChB, MD, MRCGP, MRCP is a member of the following medical societies: Royal College of Physicians
Disclosure: Nothing to disclose.

Medical Editor

Abby S Van Voorhees, MD, Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania
Abby S Van Voorhees, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, National Psoriasis Foundation, Phi Beta Kappa, Sigma Xi, and Women's Dermatologic Society
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Genentech Honoraria Consulting; Incyte Grant/research funds Other; Warner Chilcott Honoraria Consulting; Merck Salary Management position; Abbott  Speaking and teaching

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Christen M Mowad, MD, Associate Professor, Department of Dermatology, Geisinger Medical Center
Christen M Mowad, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.